Ole Wiborg
CEO
ZERION PHARMA, A/S
About me
Ole has more than 25 years executive experience in the pharma and biotech industry. He has prepared and negotiated numerous licensing and collaboration deals at all levels and is the co-founder of five companies in the life science/medtech field. In 2016 he co-founded and led the medtech company Cura Nordic until a successful exit in 2018 by way of an asset deal to Karo Pharma AB in Sweden
Attendee Access type
Attendee
Country
Denmark
Organization Type
Academic/Research
Business Activity
BiopharmaceuticalChemical Development
Markets Active In
Europe - EU countriesNorth America (e.g., USA, Canada)
Registration Type
EX
About me (Individual)
Department
General Management
Job Function
CEO/COO/President/Chairman
Purchasing Responsibility
Authorise purchase
Geographical areas you plan to expand to:
Europe - EU countriesNorth America (e.g., USA, Canada)
Offering/Interested In
Interested in: Business Type
BiopharmaceuticalChemical DevelopmentPharmaceutical Company (generic finished products)Pharmaceutical Company (innovator finished products)
Interested in: Company Type
Academic/Research
Interested In: Company Certification
GMP
Interested In: Product Certification
FDA
Interested In
Interested In: Products & Service Category
Biopharmaceuticals
Interested In: Biopharmaceuticals
Biopharmaceuticals (general category)Protein Chemistry
Content
Company
Zerion Pharma ApS
Is member of
Zerion Pharma A/S
Exhibitors
Zerion Pharma
Silver
ZERION PHARMA
Exhibitors
ZERION PHARMA, A/S
ExhibitorsIs speaking at
Using New Technologies to Improve Formulation of Poorly Soluble Drugs – Does It Matter?
Tuesday, May 7, 2024 7:50 PM to 7:55 PM
Conference Theater 2
Ole Wiborg · ZERION PHARMA, A/S